Trump Accuses FDA, Says Pfizer Is Deliberately Holding Up the Vaccine News Until the Vote Count Ends
POTUS Donald Trump accused US Food and Drug Administration Department, The Democrats and the drug maker Pfizer of conspiring to delay the announcement of advancement of the vaccine progress until after election.
Pfizer Inc. has announced that their vaccine for COVID-19 may be remarkably 90% effective against the virus. This brought a huge burst of hope and optimism around the world. However, the test is not over yet.If they finally end up working fine, then this drug might finally halt the ongoing pandemic.
The announcement was made less than a week after the election, which was almost like a trial for Trump on how he managed the pandemic situation, which killed over 1.2 million people worldwide out of which quarter million where Americans.
However, Trump didn’t seem very happy after hearing the good news as he flooded his Twitter Handle with accusation against Pfizer, US FDA on waiting for the election to pass for revealing the good news.
“As I have long said, @Pfizer and the others would only announce a Vaccine after the Election, because they didn’t have the courage to do it before. Likewise, the
@US_FDA should have announced it earlier, not for political purposes, but for saving lives,” Trump tweeted.
“The @US_FDAand the Democrats didn’t want to have me get a Vaccine WIN, prior to the election, so instead it came out five days later – As I’ve said all along!” he added.
Pfizer insisted that their work is not governed by any political part and it was “moving at the speed of science.” The company also said that they too were made aware of the progress on Sunday after a discussion with independent monitors. On the other hand, FDA has no link to Pfizer releasing the progress news and have not made any announcements by their own.
“We’re in a position potentially to be able to offer some hope,” Dr. Bill Gruber, Pfizer’s senior vice president of clinical development, told The Associated Press. “We’re very encouraged.”
Pfizer is working with a German company BioNTech for developing vaccine for COVID-19 and will be applying for emergency use approval later this month from FDA. But they will be only approved to do so when they have necessary safety information and data in hand.